MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Interest & Investment Income of $278000.0 for Q4 2025, down 73.06% on a YoY basis from $1.0 million in Q4 2024, and up 72.67% quarter-over-quarter from $161000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Interest & Investment Income for 9 years, with the latest figure at $278000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 73.06% year-over-year to $278000.0; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (down 56.14% YoY), and the FY2025 full-year result was $1.8 million, down 56.14% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $278000.0, up from $161000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.2 million in Q3 2024, with the low at $16000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $461250.0 across 5 years, with a median of $420000.0 in 2022.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 88.72% — and 2023, when it surged 3306.25%.
- MeiraGTx Holdings' Interest & Investment Income stood at $24000.0 in 2021, then soared by 1700.0% to $432000.0 in 2022, then gained by 27.08% to $549000.0 in 2023, then soared by 87.98% to $1.0 million in 2024, then sank by 73.06% to $278000.0 in 2025.
- The last three Interest & Investment Income figures came in at $278000.0 (Q4 2025), $161000.0 (Q3 2025), and $408000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Mar 31, 2025 | 971,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 827,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 549,000.00 |
| Sep 30, 2023 | 523,000.00 |
| Jun 30, 2023 | 655,000.00 |
| Mar 31, 2023 | 545,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 67,000.00 |
| Mar 31, 2021 | 89,000.00 |